10.1038/s41467-021-23925-z
10.1038/s41467-021-23925-z · doi-reference
10.1128/jvi.01202-14
10.1128/jvi.01202-14 · doi-reference
10.1016/j.jhep.2012.06.021
10.1016/j.jhep.2012.06.021 · doi-reference
10.1016/j.redox.2020.101435
10.1016/j.redox.2020.101435 · doi-reference
10.1016/j.chom.2016.07.008
10.1016/j.chom.2016.07.008 · doi-reference
10.3389/fimmu.2023.1203645
10.3389/fimmu.2023.1203645 · doi-reference
10.1002/jmv.27230
10.1002/jmv.27230 · doi-reference
10.1074/jbc.m101097200
10.1074/jbc.m101097200 · doi-reference
10.1016/bs.apcsb.2019.01.001
10.1016/bs.apcsb.2019.01.001 · doi-reference
10.1002/dneu.20609
10.1002/dneu.20609 · doi-reference
10.3389/fendo.2024.1408677
10.3389/fendo.2024.1408677 · doi-reference
10.1038/srep20352
10.1038/srep20352 · doi-reference
Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A Review
10.1007/s10571-022-01301-9 · doi-reference
Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19
10.2174/1570159x21666230616103850 · doi-reference
10.3390/nu11102356
10.3390/nu11102356 · doi-reference
10.1523/eneuro.0475-21.2022
10.1523/eneuro.0475-21.2022 · doi-reference
10.1101/2023.03.22.533736
10.1101/2023.03.22.533736 · doi-reference
10.1002/cne.25320
10.1002/cne.25320 · doi-reference
10.1016/j.steroids.2005.03.004
10.1016/j.steroids.2005.03.004 · doi-reference
10.1371/journal.ppat.1002149
10.1371/journal.ppat.1002149 · doi-reference
10.1073/pnas.1803468115
10.1073/pnas.1803468115 · doi-reference
10.1016/j.bbadis.2021.166198
10.1016/j.bbadis.2021.166198 · doi-reference
Zika Virus Infection in Pregnancy, Microcephaly, and Maternal and Fetal Health: What We Think, What We Know, and What We Think We Know
10.5858/arpa.2016-0382-ra · doi-reference
10.1152/physrev.00024.2016
10.1152/physrev.00024.2016 · doi-reference
10.1111/j.1471-4159.2008.05511.x
10.1111/j.1471-4159.2008.05511.x · doi-reference
Neuronal transcriptomic responses to Japanese encephalitis virus infection with a special focus on chemokine CXCL11 and pattern recognition receptors RIG-1 and MDA5
10.1016/j.virol.2018.10.015 · doi-reference
Neuroinflammation and blood-brain barrier disruption in Japanese encephalitis virus infection: mechanisms, therapeutic targets, and intervention strategies
10.1007/s12272-026-01598-w · doi-reference
Japanese encephalitis virus and its mechanisms of neuroinvasion
10.1371/journal.ppat.1008260 · doi-reference
10.1016/j.dscb.2025.100267
10.1016/j.dscb.2025.100267 · doi-reference
Low expression of RNA sensors impacts Zika virus infection in the lower female reproductive tract
10.1038/s41467-019-12371-7 · doi-reference
Hepatitis E viral infection regulates estrogen signaling pathways: Inhibition of the cAMPK-PKA-CREB and PI3K-AKT-mTOR signaling pathways
10.1002/jmv.26641 · doi-reference
10.1038/s41467-020-16754-z
10.1038/s41467-020-16754-z · doi-reference
10.1371/journal.pone.0145212
10.1371/journal.pone.0145212 · doi-reference
Estrogen and dementia
10.1016/j.maturitas.2022.05.005 · doi-reference
10.1016/j.neuroscience.2005.07.060
10.1016/j.neuroscience.2005.07.060 · doi-reference
Parkinson’s Disease in Women and Men: What’s the Difference?
10.3233/jpd-191683 · doi-reference
Estrogen signalling and Alzheimer’s disease: Decoding molecular mechanisms for therapeutic breakthrough
10.1111/ejn.16360 · doi-reference
10.1186/s12974-020-01998-9
10.1186/s12974-020-01998-9 · doi-reference
